{"transactions":[{"id":801768,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":51468,"kind":"person","name":"PARSLOW JAMES F","position":1,"cik":"0001285943","reported_name":"PARSLOW JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO and CFO"}}],"security":"Common Stock","published_at":"2026-04-23T21:00:02.000Z","date":"2026-04-21","kind":"grant","planned":true,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This represents a restricted stock grant (\"RSG\"). The shares represented by the RSG will vest and become exercisable as follows: 7,000 shares shall vest on the date of grant and one-third of the remaining (93,000) shares shall vest on each of the first, second and third anniversaries of April 21, 2026."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001683168-26-003163","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285943/000168316826003163/ownership.xml","form_type":"4"}},{"id":1471909,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":51468,"kind":"person","name":"PARSLOW JAMES F","position":1,"cik":"0001285943","reported_name":"PARSLOW JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO and CFO"}}],"security":"Stock Options","published_at":"2024-06-21T21:00:04.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: one-fourth of the shares shall vest on the date of grant and one-fourth of the shares shall vest on each of the first, second and third anniversaries of June 18, 2024 ending on June 18, 2027."}],"balance_after":20000,"derivative":{"exercise_price":3.99,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001683168-24-004421","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285943/000168316824004421/ownership.xml","form_type":"4"}},{"id":1712351,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":51468,"kind":"person","name":"PARSLOW JAMES F","position":1,"cik":"0001285943","reported_name":"PARSLOW JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2023-12-13T22:30:08.000Z","date":"2023-12-11","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of December 11, 2023; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on March 11, 2025 and ending on December 11, 2026."}],"balance_after":10000,"derivative":{"exercise_price":3.88,"expiration_date":"2033-12-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-23-008826","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285943/000168316823008826/ownership.xml","form_type":"4"}},{"id":2316493,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":51468,"kind":"person","name":"PARSLOW JAMES F","position":1,"cik":"0001285943","reported_name":"PARSLOW JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2022-03-28T21:14:50.000Z","date":"2022-03-24","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of March 24, 2022; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on June 24, 2023 and ending on March 24, 2025."}],"balance_after":50000,"derivative":{"exercise_price":1.12,"expiration_date":"2032-03-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001683168-22-002002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285943/000168316822002002/ownership.xml","form_type":"4"}},{"id":2776120,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":51468,"kind":"person","name":"PARSLOW JAMES F","position":1,"cik":"0001285943","reported_name":"PARSLOW JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2021-03-22T21:30:26.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of March 18, 2021; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on June 18, 2022 and ending on March 18, 2024."}],"balance_after":50000,"derivative":{"exercise_price":2.6,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001683168-21-001019","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285943/000168316821001019/ownership.xml","form_type":"4"}},{"id":3349602,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":51468,"kind":"person","name":"PARSLOW JAMES F","position":1,"cik":"0001285943","reported_name":"PARSLOW JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2019-12-06T23:42:01.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: 26,666 shares shall vest on the first anniversary of December 4, 2019 (\"Vesting Start Date\"); 26,667 shares shall vest on the second anniversary of the Vesting Start Date; and 26,667 shares shall vest on the third anniversary of the Vesting Start Date."}],"balance_after":80000,"derivative":{"exercise_price":1.31,"expiration_date":"2029-12-04","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001683168-19-003923","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285943/000168316819003923/ownership.xml","form_type":"4"}},{"id":4360580,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":51468,"kind":"person","name":"PARSLOW JAMES F","position":1,"cik":"0001285943","reported_name":"PARSLOW JAMES F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-04-04T12:08:52.000Z","date":"2017-04-03","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option will vest and become exercisable over three years, with one-third of the underlying shares vesting on each of April 3, 2018, April 3, 2019 and April 3, 2020, subject to the Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":175000,"derivative":{"exercise_price":4.57,"expiration_date":"2027-04-03","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-17-024356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285943/000120919117024356/doc4.xml","form_type":"4"}}]}